MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 07.11.2025
Akero Therapeutics P/CF 2011-2026 | AKRO
P/CF Jährlich Akero Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -14.1 | -9.89 | -17.2 | -7.75 | -14.1 | -10.5 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -7.75 | -17.2 | -12.3 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M |  Germany |
 |
Aptorum Group Limited
APM
|
-3.44 | $ 1.05 | - | $ 5.73 M |  China |
 |
Adagene
ADAG
|
-2.96 | $ 1.53 | - | $ 86.1 M | China |
 |
Autolus Therapeutics plc
AUTL
|
-2.05 | $ 1.81 | - | $ 462 M |  Britain |
 |
AstraZeneca PLC
AZN
|
13.6 | $ 94.65 | - | $ 96.9 B | Britain |
 |
Alterity Therapeutics Limited
ATHE
|
-94.9 | $ 3.52 | 5.71 % | $ 8.47 B |  Australia |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B |  USA |
 |
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | USA |
 |
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M |  France |
 |
Biogen
BIIB
|
6.73 | $ 187.62 | - | $ 27.3 B | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | Britain |
 |
Can-Fite BioPharma Ltd.
CANF
|
-413 | $ 4.14 | - | $ 9.01 B |  Israel |
 |
BioNTech SE
BNTX
|
70.7 | $ 99.85 | - | $ 27.2 B | Germany |
 |
Catalyst Biosciences
CBIO
|
1.3 | $ 10.79 | - | $ 710 M | USA |
 |
Celldex Therapeutics
CLDX
|
-0.00833 | $ 27.36 | -0.07 % | $ 1.76 M | USA |
 |
Cellectis S.A.
CLLS
|
-1.94 | $ 4.41 | - | $ 116 M | France |
 |
CorMedix
CRMD
|
-4.53 | $ 7.63 | - | $ 388 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
-17.6 | $ 202.99 | - | $ 5 B |  Danmark |
 |
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M |  Canada |
 |
Cytokinetics, Incorporated
CYTK
|
-0.0134 | $ 62.51 | - | $ 7 M | USA |
 |
DBV Technologies S.A.
DBVT
|
-6.03 | $ 17.01 | - | $ 1.65 B | France |
 |
Adaptimmune Therapeutics plc
ADAP
|
-14.6 | - | -15.15 % | $ 60.3 M | Britain |
 |
Dyadic International
DYAI
|
-7.15 | $ 0.95 | - | $ 27.4 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
-1.3 | - | 1.93 % | $ 17.4 M | USA |
 |
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | USA |
 |
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-6.14 | - | - | $ 2.17 B | USA |
 |
Enanta Pharmaceuticals
ENTA
|
-0.0134 | $ 13.11 | - | $ 280 K | USA |
 |
AlloVir
ALVR
|
-0.723 | - | 4.14 % | $ 49.1 M | USA |
 |
Equillium
EQ
|
-3.89 | $ 1.14 | - | $ 39.6 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | Israel |
 |
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
6.13 | $ 27.74 | - | $ 1.34 B | USA |
 |
Foghorn Therapeutics
FHTX
|
-2.49 | $ 5.16 | - | $ 283 M | USA |
 |
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | USA |
|
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | USA |
 |
Brickell Biotech
BBI
|
-2.62 | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
11.6 | $ 9.44 | - | $ 1.53 B | Britain |
 |
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
34.8 | $ 64.56 | - | $ 8.64 B | USA |
 |
Arena Pharmaceuticals
ARNA
|
-12.5 | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
-5.78 | - | 3.77 % | $ 22.4 M | USA |
 |
Avenue Therapeutics
ATXI
|
-0.0603 | - | -52.27 % | $ 4.45 M | USA |
 |
Abeona Therapeutics
ABEO
|
-4.04 | $ 5.19 | - | $ 111 M | USA |